发明名称 Surveillance system for adverse events during drug development studies
摘要 A method for clinical surveillance of a treatment group and an other group involves defining an adverse event, possible a serious adverse event, noting each occurrence of the adverse events, and, starting at zero, calculating a cumulative sum of the adverse events by updating the cumulative sum each time a further adverse event is reported and, when the adverse event is in the treatment group, adding 1 to the cumulative sum, and, when the adverse event is in the other group, adding 0 to the cumulative sum. This invention also involves subtracting a chosen quantity K from the cumulative sum, comparing the cumulative sum to a predetermined alarm limit, determining when the cumulative sum reaches at least the predetermined alarm limit, and indicating the predetermined alarm limit has been reached.
申请公布号 US6639515(B2) 申请公布日期 2003.10.28
申请号 US20010975814 申请日期 2001.10.11
申请人 NOVO NORDISK A/S 发明人 HOUGAARD PHILIP
分类号 G08B23/00;(IPC1-7):G08B23/00 主分类号 G08B23/00
代理机构 代理人
主权项
地址